Phone: (650) 725-0659
Russ B. Altman, MD, PhD
Dr. Altman is the Kenneth Fong Professor and Professor of Bioengineering, Genetics, Medicine, and (by courtesy) Computer Science, and is the Co-Principal Investigator of the PharmGKB. Dr. Altman has led the PharmGKB since its inception in April 2000. His research interests are in the application of computing technology to basic molecular biological problems of relevance to medicine. He is interested in developing techniques for knowledge-based scientific computation, including novel representations of biological data, particularly for pharmacogenomics. Russ holds an MD from Stanford Medical School, a PhD in medical information sciences from Stanford, and an AB from Harvard College, and is certified by the American Board of Internal Medicine.
Russ Altman is a founder and stockholder for Personalis Inc and a paid advisor for Pfizer and Karius.
Teri E. Klein, PhD
Director & Co-Principal Investigator, PharmGKB
Dr. Klein is the Director/Co-Principal Investigator for the PharmGKB and Professor of Biomedical Data Science and Medicine. Dr. Klein is also the Co-Principal Investigator for CPIC (Clinical Pharmacogenetics Implementation Consortium). She was recruited from the University of California, San Francisco faculty and has been the Director of the PharmGKB since it began in April 2000. Teri received her PhD in medical information sciences from the University of California, San Francisco and a BA in biology/chemistry from the University of California, Santa Cruz. Prior to becoming the director of the PharmGKB in 2000, Dr. Klein was an Associate Adjunct Professor at UCSF.
Michelle Whirl-Carrillo, PhD
Associate Director, PharmGKB
Dr. Whirl-Carrillo is a Senior Research Scientist in the Department of Biomedical Data Science and the Associate Director of the PharmGKB. She joined the team in 2002 after finishing her doctoral work, briefly left to develop and manage the curation team at the DTC genotyping start-up 23andMe, and returned to the PharmGKB in 2009. Her research interests include the translation of human genome sequencing data to pharmacogenomic-based therapeutic recommendations. Michelle received her PhD in Biophysics from Stanford University and her SB in Biology from MIT.
Tiffany Murray, BA
Administrative Associate/Outreach Coordinator
Tiffany coordinates the activities for the the PharmGKB co-PIs and Associate Director and is responsible for communications involving consortia, data licensing, and content use. She has a BA from the University of California at San Diego.
Katrin Sangkuhl, PhD
Katrin is a Scientific Curator in the Department of Biomedical Data Science and has been working for the Pharmacogenomics Knowledgebase (PharmGKB) since 2008. Before joining the PharmGKB team, Katrin was a Postdoctoral Fellow at the Department of Reproductive Biology & Program for Regenerative Medicine, Stanford University. She received her PhD in Biochemistry from the University Leipzig, Germany working in the field of GPCRs and signal transduction.
Li Gong, PhD
Li is a Scientific Curator in the Department of Biomedical Data Science. She joined PharmGKB in 2007. Prior to this, Li worked as a senior scientist at Iconix Biosciences Inc. working on microarray data analysis, biomarker discovery and curation for the development of DrugMatrixR toxicogenomics database. She holds a PhD in Molecular Biology and Microbiology from Tufts University School of Medicine, and a BS in Microbiology from Beijing University, P.R. China.
Ryan Whaley, BS
Ryan is a software developer in the Department of Biomedical Data Science and a co-technical lead of the PharmGKB. He is a Java developer with a background in database administration and project management and has been with the PharmGKB since 2007. Ryan received his BS in Computer Science and Mathematics at the University of Iowa and then went on to become the database administrator and senior software developer for the Department of Internal Medicine at the University of Iowa Hospitals & Clinics.
Mark Woon, BSE
Mark is the co-technical lead at PharmGKB and has been with PharmGKB since 2001. He received his BSE in computer science from Princeton University. Prior to working on the PharmGKB project, Mark worked for Sun Microsystems and Netscape Communications.
Julia Barbarino, MSc
Julia has been a Scientific Curator at PharmGKB since October 2012. She holds an MSc in Medical Molecular Genetics from the University of Aberdeen, Scotland, where her research focused on epigenetics and human longevity. In addition to her master's degree, she also holds a BS in Biochemistry from the University of California, Los Angeles.
Caroline F. Thorn, PhD
Part-time Scientific Curator
Caroline has been a Scientific Curator since 2003, when she first joined the PharmGKB. She took two hiatuses when her children were born and spent a brief time as a Senior Program Administrator for the American Association for Cancer Research and returned to the PharmGKB in 2015. She has a PhD in Genetics from Trinity College University of Dublin, BSc Hons in Biochemistry from University of Bath UK and did postdoctoral training at University of Pennsylvania in Pharmacology and pharmacogenomics. She has been a lecturer on the University of Pennsylvania Topics in Pharmacogenomics course since 2010 and one of her favorite PGx memories is teaching on the Stanford South Africa course.
Matthieu Devlin, MSc
Matt joined PharmGKB in 2015 as a software developer. He holds a MSc in Computer Science from the University of Oxford and a BSc in Mathematics from the University of St Andrews.NIH Biosketch
Ms. Paulazzo is the PharmGKB Consortia Coordinator. She assists the PharmGKB Outreach Coordinator with managing consortia relationships and activities.
Maria Alvarellos, MS
Part-time Scientific Curator
Prior to becoming a Scientific Curator with PharmGKB in 2014, Maria worked as a science curriculum developer at UC Berkeley with the Lawrence Hall of Science. She received an MS in Human Genetics from the University of Michigan, a BS in Conservation and Organismal Biology, and a BA in Anthropology from San José State University.
Jill Robinson, PhD